iSpecimen Acquires Two Foldlab AI Products for $4.5 Million
Bitget2026/11/05 21:29- iSpecimen completed the $4.5 million acquisition of two AI products from Foldlab AI on November 2, 2026.
- The products identify disease-associated proteins and predict disease trends, expanding the biospecimen marketplace into AI-powered disease intelligence.
- The purchase includes $750,000 in cash paid at closing.
- Up to $1.25 million is payable in two $625,000 milestone payments upon delivery and acceptance of applicable products.
- The remaining consideration comprises $2.5 million in common stock, totaling 2,907,977 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
